Nanjing Regenecore RT2831 project was approv¶¥ed by the State Food and Drug Adminis£★♦ tration for clinical tr≈¶π<ials
- Categories:News
- Author:
- Origin:
- Time of issue:2024-09-12
- Views:0
Nanjing Regenecore RT2831 project wε€as approved by the State Food and D>∏✘rug Administration for clinical trials
(Summary description)Regenecore will soon carry out clinical resear↑↕♦₽ch on RT2831 project in Chin±a.
- Categories:News
- Author:
- Origin:
- Time of issue:2024-09-12
- Views:0
On September 9, Nanjing Regenecore♠π© RT2831 project was approved by∞✘→ the State Food and Drug Admin™¥istration for clinical trial research. This is th™≈e second regional (China) clinicδε←←al trial approval document after the US Food"> and Drug Administration (FDA) approved the cl↕∑δinical trial license.
Nanjing Regenecore RT2831 project is a bispe←&γcific nanobody drug targe'π©$ting specific antigens on th←♠σλe surface of malignant blood t↓¥ umor cells, which has shown ≈&εexcellent safety and e∑∏≥fficacy in non clinical studies. Nan↕✘jing Regenecore will soon carry ∑©≥λout clinical research on RT2831 project iδ'★n China.
Scan the QR code to read on your phone
TEL：
Address: Room 07 Building 16♠¥ Treehouse, No. 73, Tanmi Road, Jia®♥ngbei New District, Nanjing
Enterprise email：rjk@regenecore.com
WeChat cooperative consul&§φtation
You are the th visitor
025-58608860 
Contact 